Hiroshi Kawaguchi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Hiroshi Kawaguchi has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Atsuko Hata
Department of Pediatrics, Kitano Hospital, Tazuke Kofukai Medical Research Institute, Osaka, Japan
1 shared publication Atsushi Seichi
1 shared publication- Hiroshi Kakeya
Department of Infection Control and Prevention, Osaka Metropolitan University Hospital, Osaka, Japan; Department of Infection Control Science, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan
1 shared publication Katsuya Nagayama
Department of Pharmacy, Osaka City University Hospital
1 shared publication- Katsuyuki Takahashi
Division of Social Pharmacy, Faculty of Pharmacy, Kindai University, Osaka, Japan
1 shared publication - Kazuhiro Kobayashi
Department of Pharmacy, Tazuke Kofukai Medical Research Institute, Kitano Hospital, Osaka, Japan
1 shared publication
Latest Publications
- 7 March 2024
- Published by Taylor & Francis in Journal of Chemotherapy
- Vol. 36 (7) , 521-531
Evaluation of predictors of third-generation cephalosporin non-susceptibility and factors affecting recurrence or death in bacteremia caused by Citrobacter freundii complex , Enterobacter cloacae complex, and Klebsiella aerogenes
Factors involved in the susceptibility of third-generation cephalosporins (3GCs) to bacteremia caused by Citrobacter freundii complex, Enterobacter cloacae complex, and Klebsiella aerogenes were investigated based on a case-case-control design. Antimicrobial therapy administered 30 days prior to bacteremia and hospitalization within 90 days were common risk factors for the 3GC susceptible and 3GC non-susceptible groups, while hospitalization from an institution or another hospital was a specific risk factor for the 3GC non-susceptible group. We also attempted to examine the factors affecting the clinical outcome of bacteremia. Hospitalization more than 14 days before the onset of bacteremia was an independent factor indicating poor clinical outcome. In contrast, the implementation of source control was an independent predictor of successful treatment. Although a longer hospital stay before the onset of bacteremia was associated with worse clinical outcomes, implementation of source control may have contributed to improved treatment outcomes for bacteremia.
- 7 March 2024
- Published by Taylor & Francis in Journal of Chemotherapy
- Vol. 36 (7) , 521-531
Evaluation of predictors of third-generation cephalosporin non-susceptibility and factors affecting recurrence or death in bacteremia caused by Citrobacter freundii complex , Enterobacter cloacae complex, and Klebsiella aerogenes
Factors involved in the susceptibility of third-generation cephalosporins (3GCs) to bacteremia caused by Citrobacter freundii complex, Enterobacter cloacae complex, and Klebsiella aerogenes were investigated based on a case-case-control design. Antimicrobial therapy administered 30 days prior to bacteremia and hospitalization within 90 days were common risk factors for the 3GC susceptible and 3GC non-susceptible groups, while hospitalization from an institution or another hospital was a specific risk factor for the 3GC non-susceptible group. We also attempted to examine the factors affecting the clinical outcome of bacteremia. Hospitalization more than 14 days before the onset of bacteremia was an independent factor indicating poor clinical outcome. In contrast, the implementation of source control was an independent predictor of successful treatment. Although a longer hospital stay before the onset of bacteremia was associated with worse clinical outcomes, implementation of source control may have contributed to improved treatment outcomes for bacteremia.
- Open Access
- 1 September 2015
- Published by Pharmaceutical Society of Japan in YAKUGAKU ZASSHI
- Vol. 135 (9) , 1077-1082
Introduction of a Clinical Research Experience Program in Hospital Practical Training for Pharmacy Students and Its Evaluation
総合学術電子ジャーナルサイト「J-STAGE」-国内で発行された学術論文全文を読むことのできる、日本最大級の総合電子ジャーナルプラットフォームです。
- 1 September 2015
- Published by Pharmaceutical Society of Japan in YAKUGAKU ZASSHI
- Vol. 135 (9) , 1077-1082
Open AccessIntroduction of a Clinical Research Experience Program in Hospital Practical Training for Pharmacy Students and Its Evaluation
総合学術電子ジャーナルサイト「J-STAGE」-国内で発行された学術論文全文を読むことのできる、日本最大級の総合電子ジャーナルプラットフォームです。
- 1 April 2003
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Spine
- Vol. 98 (3) , 300
Concurrent spinal schwannomas and meningiomas
- 1 April 2003
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Spine
- Vol. 98 (3) , 300
Concurrent spinal schwannomas and meningiomas